US20050202534A1 - Binding domain-immunoglobulin fusion proteins - Google Patents

Binding domain-immunoglobulin fusion proteins Download PDF

Info

Publication number
US20050202534A1
US20050202534A1 US11/089,367 US8936705A US2005202534A1 US 20050202534 A1 US20050202534 A1 US 20050202534A1 US 8936705 A US8936705 A US 8936705A US 2005202534 A1 US2005202534 A1 US 2005202534A1
Authority
US
United States
Prior art keywords
polynucleotide
cell
polypeptide
binding domain
single chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/089,367
Inventor
Jeffrey Ledbetter
Martha Hayden-Ledbetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trubion Pharmaceuticals Inc
Original Assignee
Trubion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36735801P priority Critical
Priority to US10/053,530 priority patent/US20030133939A1/en
Application filed by Trubion Pharmaceuticals Inc filed Critical Trubion Pharmaceuticals Inc
Priority to US11/089,367 priority patent/US20050202534A1/en
Publication of US20050202534A1 publication Critical patent/US20050202534A1/en
Assigned to TRUBION PHARMACEUTICALS, INC. reassignment TRUBION PHARMACEUTICALS, INC. CERTIFICATE OF AMMENDMENT OF GENECRAFT Assignors: GENECRAFT, INC.
Application status is Abandoned legal-status Critical

Links